Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial. (nature.com)

Authors: Kityo C … Paton NI Journal: Nature Medicine Published: 2026-01-01 DOI: https://doi.org/10.1038/s41591-025-04041-7